WORTHING MEDICAL GROUP — All Prescriptions & Medications — Page 6
Practice Code: H82045 | WORTHING, BN11 4BS
Showing results 251-300 of 808
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Co-dydramol (Dihydrocodeine/paracetamol) | 282 | 31.9K | £1.6K | +56.9% ▲ |
| Fludrocortisone acetate | 279 | 11.5K | £1.7K | +164.5% ▲ |
| 276 | 277 | £1.5K | +438.1% ▲ | |
| Tiotropium bromide/olodaterol | 275 | 304 | £9.4K | +348.4% ▲ |
| Fusidic acid | 269 | 6,135 | £768 | +110.7% ▲ |
| Pizotifen malate | 268 | 12.6K | £557 | +225.2% ▲ |
| 268 | 14.6K | £2.1K | +703.0% ▲ | |
| Colchicine | 264 | 7,761 | £164 | +238.5% ▲ |
| Latanoprost and timolol | 263 | 2,828 | £2.7K | +244.5% ▲ |
| 262 | 9,160 | £4.7K | +905.4% ▲ | |
| Enalapril maleate | 261 | 9,212 | £318 | +45.3% ▲ |
| Hydrocortisone | 257 | 7,270 | £1.8K | +238.4% ▲ |
| Hyoscine hydrobromide | 257 | 7,841 | £1.2K | +652.6% ▲ |
| Sodium cromoglicate | 255 | 3,547 | £832 | +174.5% ▲ |
| 254 | 15.3K | £3.6K | +215.7% ▲ | |
| 253 | 5,293 | £4.5K | +1,280.3% ▲ | |
| Clotrimazole | 244 | 2,284 | £2.6K | +121.2% ▲ |
| 242 | 4,803 | £1.6K | +1,670.9% ▲ | |
| Azithromycin | 241 | 2,708 | £787 | +90.1% ▲ |
| 241 | 13.3K | £916 | +383.0% ▲ | |
| Lymecycline | 237 | 14.8K | £1.7K | +97.0% ▲ |
| 237 | 2,470 | £589 | +718.3% ▲ | |
| Nifedipine | 236 | 13.2K | £2.7K | +25.9% ▲ |
| Dexamethasone | 236 | 3,661 | £2.1K | +295.3% ▲ |
| Vortioxetine | 235 | 4,711 | £4.4K | +238.6% ▲ |
| Nortriptyline | 233 | 15.4K | £2.1K | +60.2% ▲ |
| 231 | 1,982 | £2.1K | +641.7% ▲ | |
| Ivabradine | 230 | 11.5K | £2.5K | +141.9% ▲ |
| Benzydamine hydrochloride | 227 | 47.6K | £942 | +193.5% ▲ |
| Benzoyl peroxide and clindamycin phosphate | 227 | 11.3K | £4.5K | +238.6% ▲ |
| Hydrocortisone | 222 | 13.3K | £2.2K | +162.9% ▲ |
| 222 | 4,389 | £2.9K | +499.3% ▲ | |
| Leuprorelin acetate | 220 | 225 | £45.8K | +374.7% ▲ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 220 | 496.5K | £14.7K | +728.3% ▲ |
| Nefopam hydrochloride | 218 | 14.5K | £672 | +92.7% ▲ |
| 217 | 606 | £3.9K | +599.7% ▲ | |
| Ursodeoxycholic acid | 214 | 25.9K | £6.3K | +223.3% ▲ |
| 214 | 10.4K | £8.4K | +476.5% ▲ | |
| Rabeprazole sodium | 213 | 7,910 | £806 | +313.0% ▲ |
| Insulin degludec | 213 | 1,178 | £15.3K | +93.8% ▲ |
| Desmopressin acetate | 213 | 9,494 | £7.2K | +308.4% ▲ |
| Lacosamide | 212 | 8,446 | £4.9K | +294.5% ▲ |
| Biphasic insulin aspart | 209 | 1,985 | £11.8K | +105.8% ▲ |
| Methylprednisolone acetate | 209 | 281 | £989 | +81.0% ▲ |
| Etoricoxib | 207 | 6,986 | £2.0K | +156.9% ▲ |
| Menthol | 205 | 85.2K | £3.1K | +627.9% ▲ |
| Lisdexamfetamine dimesylate | 204 | 5,600 | £12.6K | +70.8% ▲ |
| Ropinirole hydrochloride | 204 | 6,081 | £3.4K | +92.0% ▲ |
| Valproic acid | 202 | 10.1K | £2.6K | +132.1% ▲ |
| Canagliflozin | 202 | 4,572 | £5.7K | +40.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.